Treatment of EBV and KHSV infection and associated abnormal cellular proliferation

Details for Australian Patent Application No. 2002360697 (hide)

Owner Emory University Beth Israel Deaconess Medical Center Pharmasset Inc.

Inventors Shi, Junxing; Schinazi, Raymond F; Fingeroth, Joyce D; Gustafson, Erik

Agent Davies Collison Cave

Pub. Number AU-B-2002360697

PCT Number PCT/US02/40853

PCT Pub. Number WO2003/053360

Priority 60/345,130 20.12.01 US

Filing date 19 December 2002

Wipo publication date 9 July 2003

Acceptance publication date 23 April 2009

International Classifications

C07D 239/54 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/7072 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07H 19/067 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

C07H 19/073 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 60/345,130 20.12.01 US

2 October 2003 Application Open to Public Inspection

  Published as AU-B-2002360697

3 May 2007 Change of Name(s) of Applicant(s), Section 104

  Emory University; Beth Israel Deaconess Medical Center; Pharmassett Ltd. The name of the applicant has been changed to Emory University; Beth Israel Deaconess Medical Center; Pharmassett Inc.

10 May 2007 Corrigenda

  Change of Names(s) of Applicant(s), Section 104 - 2002 Under the name Pharmassett Inc. and Emory University and Beth Israel Deaconess Medical Center, Application No. 2002360697, Under INID(71), correct the name to read Pharmasset Inc. and Emory University and Beth Israel Deaconess Medical Center

23 April 2009 Application Accepted

  Published as AU-B-2002360697

20 August 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002360698-PREPROCESSING AND PRELOADING DIGITAL DISPLAY PAGES IN MULTIPLE PAGE DIGITAL DATA FILES

2002360696-COMBINATION TREATMENT FOR MULTIPLE SCLEROSIS